The study shows that a diet high in sugar and fat causes damage to Paneth cells, immune cells in the gut that help keep inflammation in check.
When Paneth cells aren’t functioning properly, the gut immune system is excessively prone to inflammation, putting people at risk of inflammatory bowel disease and undermining effective control of disease-causing microbes.
The findings, published in Cell Host & Microbe, open up new approaches to regulating gut immunity by restoring normal Paneth cell function.
“Inflammatory bowel disease has historically been a problem primarily in Western countries such as the US, but it’s becoming more common globally as more and more people adopt Western lifestyles,” says lead author Ta-Chiang Liu, associate professor of pathology and immunology at Washington University in St. Louis.
“Our research showed that long-term consumption of a Western-style diet high in fat and sugar impairs the function of immune cells in the gut in ways that could promote inflammatory bowel disease or increase the risk of intestinal infections.”
DIET AND DAMAGED PANETH CELLS
Paneth cell impairment is a key feature of inflammatory bowel disease. For example, in people with Crohn’s disease, a kind of inflammatory bowel disease characterized by abdominal pain, diarrhea, anemia, and fatigue, these cells have often stopped working.
“OBESITY WASN’T THE PROBLEM PER SE…. IT WAS THE HIGH-FAT, HIGH-SUGAR DIET THAT WAS THE PROBLEM.”
Liu and senior author Thaddeus Stappenbeck—chair of the inflammation and immunity department at Cleveland Clinic, and former co-director of the laboratory and genomic medicine division at Washington University—set out to find the cause of Paneth cell dysfunction in people. They analyzed a database containing demographic and clinical data on 400 people, including an assessment of each person’s Paneth cells.
The researchers found that high body mass index (BMI) was associated with Paneth cells that looked abnormal and unhealthy under a microscope. The higher a person’s BMI, the worse their Paneth cells looked. The association held for healthy adults and people with Crohn’s disease.
To better understand this connection, the researchers studied two strains of mice genetically predisposed to obesity. Such mice chronically overeat because they carry mutations that prevent them from feeling full even when fed a regular diet. To the researchers’ surprise, the obese mice had Paneth cells that looked normal.
In people, obesity is frequently the result of eating a diet rich in fat and sugar. So the scientists fed normal mice a diet in which 40% of the calories came from fat or sugar, similar to the typical Western diet. After two months on this chow, the mice had become obese and their Paneth cells looked decidedly abnormal.
“Obesity wasn’t the problem per se,” Liu says. “Eating too much of a healthy diet didn’t affect the Paneth cells. It was the high-fat, high-sugar diet that was the problem.”
POINT OF NO RETURN?
The Paneth cells returned to normal when the mice were put back on a healthy mouse diet for four weeks. Whether people who habitually eat a Western diet can improve their gut immunity by changing their diet remains to be seen, Liu says.
“This was a short-term experiment, just eight weeks,” Liu says. “In people, obesity doesn’t occur overnight or even in eight weeks….We’d need to do more research before we can say whether this process is reversible in people.”
Further experiments showed that a molecule known as deoxycholic acid, a secondary bile acid formed as a byproduct of the metabolism of gut bacteria, forms the link between a Western diet and Paneth cell dysfunction. The bile acid increases the activity of two immune molecules—farnesoid X receptor and type 1 interferon—that inhibit Paneth cell function.
Liu and colleagues now are investigating whether fat or sugar plays the primary role in impairing Paneth cells. They also have begun studying ways to restore normal Paneth cell function and improve gut immunity by targeting the bile acid or the two immune molecules.
The National Institutes of Health, the Helmsley Charitable Trust, and Washington University’s Genome Technology Access Center and Digestive Disease Research Core Center funded the work.
Source: Washington University in St. Louis
Leave a Reply